Diagnostics Market is witnessing steady growth, with an estimated market valuation of USD 5.93 billion in 2023. The market is expected to expand at a CAGR of 5.81% from 2024 to 2032, driven by rising ...
Q4 2024 Earnings Call Transcript February 26, 2025 Operator: Good morning. Welcome to the Lantheus Fourth Quarter and Full Year 2024 Conference Call. [Operator Instructions]. This call is being ...
In 2021, the market was valued at USD 912.5 million, and it is projected to reach USD 1,841.2 million by 2028, growing at a CAGR of 11.0% during 2022-2028. Key factors driving this growth include: The ...
Techne's strong growth in Protein Sciences & Spatial Biology despite market pressure. Explore more details here.
The Santa Clara, California-based firm said that its diagnostics and life sciences revenues rose 4 percent year over year.
According to FutureWise analysis the market for Artificial Intelligence in Digital Pathology in 2023 is US$ 0.33 billion, and is expected to reach US$ 1.17 billion by 2031 at a CAGR of 17%.Digital ...
A Shaker Heights-based biotech company has raised $20 million to develop a diagnostic platform that it says will simplify ...
Myriad Genetics (NASDAQ:MYGN – Get Free Report) had its price objective dropped by investment analysts at UBS Group from ...
The peptide synthesis market is expanding rapidly, driven by the rising incidence of chronic diseases like cancer, diabetes, and cardiovascular conditions. This surge in demand is fueled by the ...
The London Company Large Cap portfolio returned 0.8% during the quarter vs. a 2.0% decrease in the Russell 1000 Value Index.
Fourth quarter revenue growth of 28% to $24.7 million2024 revenue growth of 28% to $90.0 million68% improvement in adjusted EBITDA in fourth ...